应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RDY 如瑞迪博士
已收盘 03-05 16:00:00 EST
14.27
-0.01
-0.07%
盘后
14.27
+0.00
0.00%
19:26 EST
最高
14.32
最低
14.16
成交量
197.57万
今开
14.19
昨收
14.28
日振幅
1.12%
总市值
119.10亿
流通市值
85.00亿
总股本
8.35亿
成交额
2,814万
换手率
0.33%
流通股本
5.96亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
消息称如瑞迪博士或于三月在印度推出仿制索马鲁肽注射剂Obeda
美股速递 · 02-25
消息称如瑞迪博士或于三月在印度推出仿制索马鲁肽注射剂Obeda
财报前瞻|如瑞迪博士本季度营收预计增4.91%,机构观点偏中性
财报Agent · 01-14
财报前瞻|如瑞迪博士本季度营收预计增4.91%,机构观点偏中性
异动解读 | 如瑞迪博士盘中大跌5.1% 或受业绩利空打压
异动解读 · 2025-01-23
异动解读 | 如瑞迪博士盘中大跌5.1% 或受业绩利空打压
如瑞迪博士盘中异动 早盘股价大跌5.10%报14.32美元
市场透视 · 2025-01-23
如瑞迪博士盘中异动 早盘股价大跌5.10%报14.32美元
Dr Reddy's Laboratories 2025年第三季度GAAP每股收益0.20美元,同比0.19美元,销售额9.77亿美元,同比增长8.43亿美元
财报速递 · 2025-01-23
Dr Reddy's Laboratories 2025年第三季度GAAP每股收益0.20美元,同比0.19美元,销售额9.77亿美元,同比增长8.43亿美元
如瑞迪博士盘中异动 大幅拉升5.15%报15.30美元
市场透视 · 2024-12-19
如瑞迪博士盘中异动 大幅拉升5.15%报15.30美元
如瑞迪博士2024财年第三财季实现净利润1.50亿美元,同比减少16.20%
市场透视 · 2024-11-11
如瑞迪博士2024财年第三财季实现净利润1.50亿美元,同比减少16.20%
如瑞迪博士盘中异动 大幅拉升5.03%
市场透视 · 2024-11-06
如瑞迪博士盘中异动 大幅拉升5.03%
加载更多
公司概况
公司名称:
如瑞迪博士
所属市场:
NYSE
上市日期:
--
主营业务:
如瑞迪博士实验室有限公司成立于1984年2月24日,其一体化的全球制药公司通过其三个核心业务部门:全球仿制药分部,医药服务与活性成分部门(PSAI)和专有产品分部,致力于提供价格优惠的新型药物。其全球品牌和无品牌仿制药部分包括处方药和非处方药(OTC)药品经营。公司的医药服务与活性成分部门(PSAI)成由药物成分(API)业务和药学服务定制组成。公司专利产品部分下设生物制药企业,新化学实体业务,分化配方业务及通过promius制药公司运营的皮肤科专业的业务重点企业。
发行价格:
--
{"stockData":{"symbol":"RDY","market":"US","secType":"STK","nameCN":"如瑞迪博士","latestPrice":14.27,"timestamp":1772744400000,"preClose":14.28,"halted":0,"volume":1975684,"hourTrading":{"tag":"盘后","latestPrice":14.27,"preClose":14.27,"latestTime":"19:26 EST","volume":6622,"amount":94494.8121,"timestamp":1772756812922,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0007002801120448031,"floatShares":595667231,"shares":834613760,"eps":0.756763,"marketStatus":"已收盘","change":-0.01,"latestTime":"03-05 16:00:00 EST","open":14.19,"high":14.32,"low":14.1601,"amount":28144262.652984,"amplitude":0.011197,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.756763,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1772787600000},"marketStatusCode":5,"adr":1,"adrRate":1,"listingDate":986961600000,"exchange":"NYSE","adjPreClose":14.28,"dividendRate":0.006188,"preHourTrading":{"tag":"盘前","latestPrice":14.76,"preClose":14.28,"latestTime":"08:00 EST","volume":70,"amount":1033.2,"timestamp":1772715604767,"change":0.48,"changeRate":0.033613,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":14.27,"preClose":14.27,"latestTime":"19:26 EST","volume":6622,"amount":94494.8121,"timestamp":1772756812922,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.185471,"impliedVol":0.3603,"impliedVolPercentile":0.6335},"requestUrl":"/m/hq/s/RDY","defaultTab":"news","newsList":[{"id":"1174309909","title":"消息称如瑞迪博士或于三月在印度推出仿制索马鲁肽注射剂Obeda","url":"https://stock-news.laohu8.com/highlight/detail?id=1174309909","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174309909?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:01","pubTimestamp":1772006461,"startTime":"0","endTime":"0","summary":"据知情人士透露,如瑞迪博士实验室有限公司计划于今年三月在印度市场推出一款名为Obeda的仿制索马鲁肽注射剂。该产品预计将用于糖尿病治疗领域。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU0820561909.HKD","LU0006306889.USD","SG9999015978.USD","LU2168563687.JPY","LU2361045086.USD","LU0689472784.USD","LU2471134952.CNY","IE00B4JS1V06.HKD","RDY","LU0256863811.USD","LU2237438978.USD","LU2552382215.SGD","LU2111349929.HKD","LU2237443895.HKD","BK4534","IE0002141913.USD","LU2552382132.HKD","IE00B2B36J28.USD","LU0094547139.USD","IE00BKDWB100.SGD","LU0385154629.USD","LU2089283258.USD","LU1551013425.SGD","LU2213496289.HKD","LU1548497426.USD","LU2756315664.SGD","LLYX","SGXZ81514606.USD","LU2168564065.EUR","LU2756315318.SGD","LU1988902786.USD","LU0106261372.USD","LU0353189763.USD","LU0820562030.AUD","LU2746668974.SGD","LU2360106947.USD","IE00B775H168.HKD","LU0158827781.USD","LU2237443622.USD","IE00B7KXQ091.USD","LU0432979614.USD","IE0001KFT4U8.USD","IE00BJJMRZ35.SGD","LU2023250504.SGD","LLII","LU2112291526.USD","BK4007","IE0004445015.USD","LU2168564495.EUR","LU1868836914.USD","LU0320765992.SGD","IE00B4R5TH58.HKD","LU0471298777.SGD","BK4585","LU0683600562.USD","LU1366192091.USD","IE00BN29S564.USD","SG9999014898.SGD","LU0353189680.USD","IE00B1XK9C88.USD","BK4581","LU1720051108.HKD","BK4599","LU0114720955.EUR","LU1023059063.AUD","LU2491050071.SGD","LU0234572021.USD","LU0058720904.USD","LU0238689110.USD","LU2028103732.USD","LU0708995401.HKD","LU0823416689.USD","LU2089984988.USD","LU2462157665.USD","LU1093756325.SGD","LU0097036916.USD","LU2491049909.HKD","LU0109391861.USD","LU0316494557.USD","IE00BK4W5L77.USD","LU1061106388.HKD","LU1127390331.HKD","IE00BJJMRX11.SGD","IE00BK4W5M84.HKD","LU0787776722.HKD","LU2023250330.USD","LU0203201768.USD","LU2324357040.USD","SG9999014906.USD","LU1868837300.USD","LU2471134523.USD","LU1093756168.USD","SG9999001176.USD","LU0061475181.USD","LU2750360997.AUD","LU1291159041.SGD","LU1551013342.USD","LU2023251221.USD","LU0225283273.USD","LU2106854487.HKD","LU0823434740.USD","LU1035775433.USD","LU2361044865.SGD","LU0640476718.USD","LU0823434583.USD","LU1280957306.USD","LU0471298694.HKD","LU0323591593.USD","SGXZ31699556.SGD","LU0122379950.USD","LU0289739699.SGD","LU1145028129.USD","LU2063271972.USD","LU2089284900.SGD","LU2471134879.HKD","LU0417517546.SGD","LU2552382058.USD","ELIS","LU0256863902.USD","LU2211815571.USD","LU0158827948.USD","LU2491050154.USD","SG9999001176.SGD","IE0005OL40V9.USD","IE00BJLML261.HKD","LU1064131342.USD","LU2461242641.AUD","ELIL","BK4588","LU0882574139.USD","IE00B1BXHZ80.USD","LU1868836591.USD","LU2271345857.HKD","IE00BJJMRY28.SGD","LU0456855351.SGD","LU1623119135.USD","LU0203202063.USD","BK4516","LU1267930730.SGD","LU1804176565.USD","LU2264538146.SGD","LU2456880835.USD","LU0672654240.SGD","SG9999013999.USD","SG9999018865.SGD","SGXZ57979304.SGD","LU0354030511.USD","SG9999015945.SGD","LU0354030438.USD","BK4533","SG9999017495.SGD","LU1814569148.SGD","LU1629891620.HKD","IE00BWXC8680.SGD","LU2750360641.GBP","LU2361044949.HKD","LU2468319806.SGD","LU2087625088.SGD","IE00BFSS7M15.SGD","LU2237443382.USD","LU2237443978.SGD","LU1323610961.USD","LU1868836757.USD","SG9999014880.SGD","LU0198837287.USD","LU2108987350.USD","LU2746668461.USD","IE00BKPKM429.USD","LU0882574055.USD","SGXZ99366536.SGD","LU2471134796.USD","LU0964807845.USD","LU0109394709.USD","LU2357305700.SGD","IE0004445239.USD","LU0320765059.SGD","IE00BFSS8Q28.SGD","SG9999015986.USD","LLYZ","LU2265009873.SGD","LU2896262040.SGD","LU2168564222.USD","LU2237443465.HKD","SGXZ51526630.SGD","LU0889565916.HKD","SG9999015952.SGD","LU2417539215.USD","LU0096364046.USD","LU0820561818.USD","LU2602419157.SGD","IE00BFTCPJ56.SGD","LU2168564149.EUR","SG9999014914.USD","LU1989771016.USD","GB00BDT5M118.USD","LU1057294990.SGD","LU1868837136.USD","IE0009355771.USD","LU0466842654.USD","LU1917777945.USD","LU1720051017.SGD","LU2237443549.SGD","LU1069344957.HKD","LU1712237335.SGD","LU0079474960.USD","LU1974910355.USD","LU0266013472.USD","LU0210536198.USD","LU2236285917.USD","LU0943347566.SGD","LU1232071149.USD","SG9999018857.SGD","LU0786609619.USD","LU1983299246.USD"],"gpt_icon":0},{"id":"1113007101","title":"财报前瞻|如瑞迪博士本季度营收预计增4.91%,机构观点偏中性","url":"https://stock-news.laohu8.com/highlight/detail?id=1113007101","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113007101?lang=zh_cn&edition=full","pubTime":"2026-01-14 10:11","pubTimestamp":1768356696,"startTime":"0","endTime":"0","summary":"如瑞迪博士将于2026年01月21日发布最新季度财报,市场关注收入与盈利的结构变化及EPS走势。市场一致预期显示,如瑞迪博士本季度总收入预计为85.47亿美元,同比增4.91%;毛利率、净利率及调整后每股收益的预测在公开渠道暂未提供权威一致数据,公司的对本季度预测信息也仅披露了收入、EBIT与EPS的区间,预计EBIT为13.75亿美元,同比降18.54%,预计EPS为14.10美元,同比降15.38%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻|如瑞迪博士本季度营收预计增4.91%,机构观点偏中性","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RDY"],"gpt_icon":0},{"id":"1174309415","title":"异动解读 | 如瑞迪博士盘中大跌5.1% 或受业绩利空打压","url":"https://stock-news.laohu8.com/highlight/detail?id=1174309415","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174309415?lang=zh_cn&edition=full","pubTime":"2025-01-23 23:12","pubTimestamp":1737645150,"startTime":"0","endTime":"0","summary":"如瑞迪博士(RDY.US)股价今日盘中出现大幅下跌,最高下挫逾5.1%。\n\n分析指出,这一走低行情或与公司近期财报利空有关。如瑞迪博士近期公布的2025财年第三季度财报显示,公司当季每股收益为0.20美元,与去年同期持平。而公司季度营收则为9.77亿美元,同比增长15.9%。从财报数据来看,公司业绩增长较为乏力,未有亮眼表现,这或令市场失望,减弱了投资者信心,从而引发股价下跌。\n\n不过,由于公司整体经营状况尚可,市场分析人士预计,股价下跌幅度或将受到一定限制。后续公司还需在投资者关系管理方面进一步加强,以稳定投资者信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RDY"],"gpt_icon":0},{"id":"2505012923","title":"如瑞迪博士盘中异动 早盘股价大跌5.10%报14.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505012923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505012923?lang=zh_cn&edition=full","pubTime":"2025-01-23 23:04","pubTimestamp":1737644694,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日23时04分,如瑞迪博士股票出现异动,股价急速下挫5.10%。截至发稿,该股报14.32美元/股,成交量17.8924万股,换手率0.02%,振幅4.01%。最近的财报数据显示,该股实现营业收入9.57亿美元,净利润1.50亿美元,每股收益0.18美元,毛利5.44亿美元,市盈率18.17倍。机构评级方面,在所有39家参与评级的机构中,41%的券商给予买入建议,33%的券商给予持有建议,26%的券商给予卖出建议。如瑞迪博士股票所在的制药行业中,整体跌幅为0.28%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123230455960e4b27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123230455960e4b27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4523","BK4596","LU0348744763.USD","BK4557","BK4007","RDY","BK4532"],"gpt_icon":0},{"id":"1171469608","title":"Dr Reddy's Laboratories 2025年第三季度GAAP每股收益0.20美元,同比0.19美元,销售额9.77亿美元,同比增长8.43亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1171469608","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171469608?lang=zh_cn&edition=full","pubTime":"2025-01-23 20:50","pubTimestamp":1737636634,"startTime":"0","endTime":"0","summary":"Dr Reddy's Laboratories 2025年第三季度GAAP每股收益为0.20美元,同比为0.19美元,销售额为9.77亿美元,而去年同期为8.43亿美元以上内容来自Benzinga Earnings专栏,原文如下:Dr Reddy's Laboratories Q3 2025 GAAP EPS $0.20 Versus $0.19 YoY, Sales $977.00M Compared To $843M YoY","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Dr Reddy's Laboratories 2025年第三季度GAAP每股收益0.20美元,同比0.19美元,销售额9.77亿美元,同比增长8.43亿美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RDY"],"gpt_icon":0},{"id":"2492584179","title":"如瑞迪博士盘中异动 大幅拉升5.15%报15.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492584179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492584179?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:30","pubTimestamp":1734618633,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时30分,如瑞迪博士股票出现波动,股价急速拉升5.15%。截至发稿,该股报15.30美元/股,成交量7.1198万股,换手率0.01%,振幅0.07%。最近的财报数据显示,该股实现营业收入9.57亿美元,净利润1.50亿美元,每股收益0.18美元,毛利5.44亿美元,市盈率19.18倍。如瑞迪博士股票所在的制药行业中,整体涨幅为0.00%。如瑞迪博士公司简介:Dr. Reddy's Laboratories Ltd 总部位于印度,开发和制造销往世界各地的仿制药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223033ab849ddf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223033ab849ddf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","BK4557","BK4596","RDY","LU0348744763.USD","BK4523","BK4007"],"gpt_icon":0},{"id":"2482267393","title":"如瑞迪博士2024财年第三财季实现净利润1.50亿美元,同比减少16.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482267393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482267393?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:00","pubTimestamp":1731254428,"startTime":"0","endTime":"0","summary":"11月11日,如瑞迪博士公布财报,公告显示公司2024财年第三财季净利润为1.50亿美元,同比减少16.20%;其中营业收入为9.57亿美元,同比增加15.02%,每股基本收益为0.18美元。从资产负债表来看,如瑞迪博士总负债18.70亿美元,其中短期债务4.91亿美元,资产负债比为2.98,流动比率为1.92。机构评级:截至2024年11月11日,当前有37家机构对如瑞迪博士目标价做出预测,其中目标均价为16.22美元,其中最低目标价为12.70美元,最高目标价为19.64美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000048a229e378&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000048a229e378&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RDY"],"gpt_icon":0},{"id":"2481998549","title":"如瑞迪博士盘中异动 大幅拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481998549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481998549?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:30","pubTimestamp":1730903458,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时30分,如瑞迪博士股票出现异动,股价大幅上涨5.03%。截至发稿,该股报15.35美元/股,成交量1.5724万股,换手率0.00%,振幅0.27%。机构评级方面,在所有37家参与评级的机构中,32%的券商给予买入建议,35%的券商给予持有建议,33%的券商给予卖出建议。如瑞迪博士股票所在的制药行业中,整体涨幅为0.00%。如瑞迪博士公司简介:Dr. Reddy's Laboratories Ltd 总部位于印度,开发和制造销往世界各地的仿制药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223106a21d29d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223106a21d29d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU0348744763.USD","BK4557","BK4532","BK4523","RDY","BK4596"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.drreddys.com","stockEarnings":[{"period":"1week","weight":-0.0219},{"period":"1month","weight":0.0492},{"period":"3month","weight":0.0099},{"period":"6month","weight":-0.0042},{"period":"1year","weight":0.1148},{"period":"ytd","weight":0.0171}],"compareEarnings":[{"period":"1week","weight":-0.0116},{"period":"1month","weight":-0.0148},{"period":"3month","weight":0.0011},{"period":"6month","weight":0.0585},{"period":"1year","weight":0.1877},{"period":"ytd","weight":0.0047}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"如瑞迪博士实验室有限公司成立于1984年2月24日,其一体化的全球制药公司通过其三个核心业务部门:全球仿制药分部,医药服务与活性成分部门(PSAI)和专有产品分部,致力于提供价格优惠的新型药物。其全球品牌和无品牌仿制药部分包括处方药和非处方药(OTC)药品经营。公司的医药服务与活性成分部门(PSAI)成由药物成分(API)业务和药学服务定制组成。公司专利产品部分下设生物制药企业,新化学实体业务,分化配方业务及通过promius制药公司运营的皮肤科专业的业务重点企业。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.02128},{"month":2,"riseRate":0.36,"avgChangeRate":-0.014116},{"month":3,"riseRate":0.68,"avgChangeRate":0.03293},{"month":4,"riseRate":0.625,"avgChangeRate":0.025232},{"month":5,"riseRate":0.48,"avgChangeRate":-0.002855},{"month":6,"riseRate":0.68,"avgChangeRate":0.048941},{"month":7,"riseRate":0.4,"avgChangeRate":0.006857},{"month":8,"riseRate":0.48,"avgChangeRate":-0.006678},{"month":9,"riseRate":0.6,"avgChangeRate":0.021647},{"month":10,"riseRate":0.56,"avgChangeRate":0.011791},{"month":11,"riseRate":0.68,"avgChangeRate":0.00989},{"month":12,"riseRate":0.52,"avgChangeRate":0.035201}],"exchange":"NYSE","name":"如瑞迪博士","nameEN":"Dr Reddy's Laboratories"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"如瑞迪博士(RDY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供如瑞迪博士(RDY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"如瑞迪博士,RDY,如瑞迪博士股票,如瑞迪博士股票老虎,如瑞迪博士股票老虎国际,如瑞迪博士行情,如瑞迪博士股票行情,如瑞迪博士股价,如瑞迪博士股市,如瑞迪博士股票价格,如瑞迪博士股票交易,如瑞迪博士股票购买,如瑞迪博士股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"如瑞迪博士(RDY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供如瑞迪博士(RDY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}